At the Ophthalmology Futures Forum, EyeYon Medical shared an important milestone in the journey of EndoArt® — two years since the start of its limited market release.
Our CEO- Nahum Ferera presented how EndoArt® has evolved from a pioneering innovation into a transformative clinical reality, now reaching more than 600 successful implantations worldwide and demonstrating its growing role in the treatment of corneal edema.
The session highlighted EyeYon’s continued commitment to expanding access to care, addressing the global shortage of donor tissue, and shaping the next generation of endothelial therapy.
EndoArt® continues to redefine corneal care – and this is only the beginning.
Watch the session and explore more on our LinkedIn page:
https://www.linkedin.com/posts/eyeyon-medical_eyeyon-medical-nahum-ferera-copenhagen-activity-7378745435445825536-BAXe
